Vasoconstrictor Agents

"Vasoconstrictor Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used to cause constriction of the blood vessels.

Descriptor ID	D014662
MeSH Number(s)	D27.505.954.411.793
Concept/Terms	Vasoconstrictor Agents Vasoconstrictor Agents Agents, Vasoconstrictor Vasoconstrictor Drugs Drugs, Vasoconstrictor Vasoconstrictors Vasoactive Agonists Agonists, Vasoactive Vasopressor Agents Agents, Vasopressor

Below are MeSH descriptors whose meaning is more general than "Vasoconstrictor Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Vasoconstrictor Agents [D27.505.954.411.793]

Below are MeSH descriptors whose meaning is related to "Vasoconstrictor Agents".

Below are MeSH descriptors whose meaning is more specific than "Vasoconstrictor Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vasoconstrictor Agents" by people in this website by year, and whether "Vasoconstrictor Agents" was a major or minor topic of these publications.

Bar chart showing 120 publications over 29 distinct years, with a maximum of 10 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	2	3
1997	2	0	2
1998	1	0	1
1999	1	1	2
2000	0	2	2
2001	3	2	5
2002	2	3	5
2003	1	3	4
2004	6	4	10
2005	1	1	2
2006	1	6	7
2007	2	4	6
2008	1	1	2
2009	0	2	2
2010	1	4	5
2011	2	3	5
2012	4	1	5
2013	0	2	2
2014	4	1	5
2015	2	3	5
2016	1	3	4
2017	5	0	5
2018	0	4	4
2019	2	3	5
2020	1	6	7
2021	2	2	4
2022	0	2	2
2023	2	2	4
2024	1	4	5

Below are the most recent publications written about "Vasoconstrictor Agents" by people in Profiles.

Berkenbush M, Singh L, Sessa K, Saadi R. Scoping Review: Is Push-Dose Norepinephrine a Better Choice? West J Emerg Med. 2024 Sep; 25(5):708-714.

View in: PubMed
Kienzle MF, Morgan RW, Reeder RW, Ahmed T, Berg RA, Bishop R, Bochkoris M, Carcillo JA, Carpenter TC, Cooper KK, Diddle JW, Federman M, Fernandez R, Franzon D, Frazier AH, Friess SH, Frizzola M, Graham K, Hall M, Horvat C, Huard LL, Maa T, Manga A, McQuillen PS, Meert KL, Mourani PM, Nadkarni VM, Naim MY, Pollack MM, Sapru A, Schneiter C, Sharron MP, Tabbutt S, Viteri S, Wolfe HA, Sutton RM. Epinephrine Dosing Intervals Are Associated With Pediatric In-Hospital Cardiac Arrest Outcomes: A Multicenter Study. Crit Care Med. 2024 Sep 01; 52(9):1344-1355.

View in: PubMed
Gordon ER, Trager MH, Samie FH, Humphreys TR. Part 2: Management of intraoperative and perioperative bleeding. J Am Acad Dermatol. 2025 Mar; 92(3):407-416.

View in: PubMed
Anand T, Hejazi O, Conant M, Joule D, Lundy M, Colosimo C, Spencer A, Nelson A, Magnotti L, Joseph B. Impact of resuscitation adjuncts on postintubation hypotension in patients with isolated traumatic brain injury. J Trauma Acute Care Surg. 2024 Jul 01; 97(1):112-118.

View in: PubMed
Haber EN, Sonti R, Simkovich SM, Pike CW, Boxley CL, Fong A, Weintraub WS, Cobb NK. Accuracy of Noninvasive Blood Pressure Monitoring in Critically Ill Adults. J Intensive Care Med. 2024 07; 39(7):665-671.

View in: PubMed
Wang VS, Kosman J, Yuan H, Lauritsen C, Shrewsbury S, Aurora SK, Hopkins M, Silberstein S. Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study. Headache. 2023 10; 63(9):1251-1258.

View in: PubMed
Mastrolonardo EV, Lu JS, Elliott Z, Knops A, Philips R, Urdang Z, Mady LJ, Curry JM. Evaluating the impact of hemodynamic support measures on head and neck free tissue transfer outcomes: A population-based analysis. Oral Oncol. 2023 08; 143:106461.

View in: PubMed
Min KJ, Owrey MW. The hidden costs of normal saline: Increased transfusions and vasopressor infusions. J Clin Anesth. 2023 09; 88:111141.

View in: PubMed
Wenner MM, Welti LM, Dow CA, Greiner JJ, Stauffer BL, DeSouza CA. Aerobic exercise training reduces ET-1-mediated vasoconstriction and improves endothelium-dependent vasodilation in postmenopausal women. Am J Physiol Heart Circ Physiol. 2023 06 01; 324(6):H732-H738.

View in: PubMed
Peng K, McIlroy DR, Bollen BA, Billings FT, Zarbock A, Popescu WM, Fox AA, Shore-Lesserson L, Zhou S, Geube MA, Ji F, Bhatia M, Schwann NM, Shaw AD, Liu H. Society of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery. Anesth Analg. 2022 10 01; 135(4):744-756.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement